Syracuse, NY, United States of America

Michael T McMahon

This inventor holds 58 USPTO granted patents and 7 published patent applications, primarily in Medical Devices (CPC class A61B). Top assignees: Welch Allyn, Inc., Miltex, Inc.. Active years: 2002-2025.

USPTO Granted Patents = 58 

% Patents Active = 87.9

Average Co-Inventor Count = 5.4

ph-index = 21

Forward Citations = 2,244(Granted Patents)

Forward Citations (Not Self Cited) = 2,091(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Syracuse, NY (US) (2002 - 2022)
  • Skaneateles Falls, NY (US) (2014 - 2024)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Areas of Expertise:
Vaginal Speculum
Medical Viewing Device
Patient Monitoring
Medical Examination System
Illuminator
Handheld Device
Diagnostic Instrument
Capacitor Powered
Physical Assessment
Wearable Patch
Blood Pressure Sleeve
Articulation Mechanism
58 patents (USPTO):Explore Patents

Title: The Inventor Profile of Michael T McMahon

Introduction: Michael T McMahon is a renowned inventor based in Syracuse, NY, known for his groundbreaking contributions to various fields.

Latest Patents: Michael T McMahon holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of innovations.

Career Highlights: With a career spanning over two decades, Michael T McMahon has established himself as a prolific inventor with a keen eye for identifying gaps in the market and developing unique solutions.

Collaborations: Throughout his career, Michael T McMahon has collaborated with leading companies, research institutions, and universities to bring his inventions to life, highlighting his ability to work across different sectors.

Conclusion: Michael T McMahon's innovative spirit and dedication to pushing the boundaries of technology make him a standout figure in the world of inventions and patents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…